Abstract
Background Oxidative stress, the imbalance between production and removal of reactive oxygen species (ROS), is implicated in the process of cardiovascular aging. Membrane-associated NAD(P)H oxidase system is the most important source of ROS in vascular cells. p22 phox , a critical component of the NAD(P)H oxidase, has a polymorphic site on exon 4, associated with variable enzyme activity. The goal of this study is to investigate the effect of the p22 phox C242T polymorphism on cardiovascular aging. Methods We investigated, in a cross-sectional study, the distribution of the p22 phox genotypes and its impact on vascular aging in elderly Korean subjects ( N = 123, mean age ± SD: 97.0 ± 5.0). p22 phox C242T polymorphism was determined by PCR and restriction fragment length polymorphism analysis. The p22 phox genotype and allele frequencies were also compared with younger Korean subjects ( N = 363, mean age ± SD: 49.0 ± 10.3). Results No significant difference was identified in p22 phox genotype frequency according to the subject's age. However, the prevalence of CT + TT genotype was significantly less frequent in normotensive extremely elderly compared with younger subjects. Furthermore, the prevalence of the CT + TT genotype was significantly more frequent in hypertensive subjects (21.9%) than in the normotensive group (6.0%, P = 0.016) in extremely elderly subject. The association was more significant in systolic hypertension rather than diastolic hypertension. Mean systolic blood pressure and pulse pressure were also significantly higher in subjects with CT + TT genotype. In contrast, there was no significant association between p22 phox genotype and hypertension in younger–aged group. Conclusion These results suggest an association between the p22 phox C242T polymorphism and vascular aging, which might be mediated by the increase of oxidative stress.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.